LIAISON XL HCG— 510(k) K131037

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K131037 for LIAISON XL HCG, Substantially Equivalent on 2013-09-06. Applicant: DiaSorin, Inc..

Clearance details

Applicant: DiaSorin, Inc.
Product code: Code DHA
Advisory panel: Clinical Chemistry
Date received: 2013-04-15
Decision date: 2013-09-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Stillwater, MN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DHA

product code DHA

Malfunction: 1,242
Total: 1,242

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.